AIM IMMUNOTECH INC. Manufacturing Costs
AIM IMMUNOTECH INC. (AIM) reported Manufacturing Costs of $5.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ManufacturingCosts · last filed 2026-08-07
- AIM IMMUNOTECH INC. manufacturing costs for the quarter ending 2026-06-30 was $5.00K, a 50.00% decline year-over-year.
- AIM IMMUNOTECH INC. manufacturing costs for the quarter ending 2026-03-31 was $4.00K, a 60.00% decline year-over-year.
- AIM IMMUNOTECH INC. manufacturing costs for the quarter ending 2025-12-31 was $40.00K, a 471.43% increase year-over-year.
- AIM IMMUNOTECH INC. manufacturing costs for the quarter ending 2025-09-30 was $68.00K, a 750.00% increase year-over-year.
- AIM IMMUNOTECH INC. manufacturing costs for fiscal 2025 was $128.00K, a 312.90% increase from fiscal 2024.
- AIM IMMUNOTECH INC. manufacturing costs for fiscal 2024 was $31.00K, a 26.19% decline from fiscal 2023.
- AIM IMMUNOTECH INC. manufacturing costs for fiscal 2023 was $42.00K.
- AIM IMMUNOTECH INC. manufacturing costs for fiscal 2021 was $850.00K, a 5.46% increase from fiscal 2020.
| Period end | Manufacturing Costs 3 month | Manufacturing Costs 6 month | Manufacturing Costs 9 month | Manufacturing Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-07 | $9.00K 10-Q · filed 2026-08-07 | $49.00K derived: sum of 3 quarters · filed 2026-08-07 | $117.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-15 | $44.00K derived: sum of 2 quarters · filed 2026-05-15 | $112.00K derived: sum of 3 quarters · filed 2026-05-15 | $122.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $108.00K derived: sum of 2 quarters · filed 2026-03-27 | $118.00K derived: sum of 3 quarters · filed 2026-08-07 | $128.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $68.00K 10-Q · filed 2025-11-17 | $78.00K derived: sum of 2 quarters · filed 2026-08-07 | $88.00K 10-Q · filed 2025-11-17 | $95.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $10.00K 10-Q · filed 2026-08-07 | $20.00K 10-Q · filed 2026-08-07 | $27.00K derived: sum of 3 quarters · filed 2026-08-07 | $35.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-15 | $17.00K derived: sum of 2 quarters · filed 2026-05-15 | $25.00K derived: sum of 3 quarters · filed 2026-05-15 | $33.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $15.00K derived: sum of 2 quarters · filed 2026-03-27 | $23.00K derived: sum of 3 quarters · filed 2026-03-27 | $31.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $8.00K 10-Q · filed 2025-11-17 | $16.00K derived: sum of 2 quarters · filed 2025-11-17 | $24.00K 10-Q · filed 2025-11-17 | $36.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $8.00K 10-Q · filed 2025-08-14 | $16.00K 10-Q · filed 2025-08-14 | $28.00K derived: sum of 3 quarters · filed 2025-08-14 | $58.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-15 | $20.00K derived: sum of 2 quarters · filed 2025-05-15 | $50.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $42.00K derived: sum of 2 quarters · filed 2025-03-27 | $42.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $30.00K 10-Q · filed 2024-11-14 | $30.00K 10-Q · filed 2024-11-14 | ||
| 2022-06-30 | $69.00K 10-Q · filed 2023-08-14 | $147.00K 10-Q · filed 2023-08-14 | $322.00K derived: sum of 3 quarters · filed 2023-08-14 | $479.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $77.00K 10-Q · filed 2023-05-15 | $253.00K derived: sum of 2 quarters · filed 2023-05-15 | $410.00K derived: sum of 3 quarters · filed 2023-05-15 | $689.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $333.00K derived: sum of 2 quarters · filed 2023-03-31 | $612.00K derived: sum of 3 quarters · filed 2023-03-31 | $850.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $157.00K 10-Q · filed 2022-11-14 | $436.00K derived: sum of 2 quarters · filed 2022-11-14 | $674.00K 10-Q · filed 2022-11-14 | $871.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $279.00K 10-Q · filed 2022-08-15 | $517.00K 10-Q · filed 2022-08-15 | $714.00K derived: sum of 3 quarters · filed 2022-08-15 | $918.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $237.00K 10-Q · filed 2022-05-13 | $435.00K derived: sum of 2 quarters · filed 2022-05-13 | $639.00K derived: sum of 3 quarters · filed 2022-05-13 | $839.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $402.00K derived: sum of 2 quarters · filed 2022-03-31 | $602.00K derived: sum of 3 quarters · filed 2022-03-31 | $806.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $204.00K 10-Q · filed 2021-11-15 | $404.00K derived: sum of 2 quarters · filed 2021-11-15 | $608.00K 10-Q · filed 2021-11-15 | $825.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-16 | $404.00K 10-Q · filed 2021-08-16 | $621.00K derived: sum of 3 quarters · filed 2021-08-16 | $851.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $204.00K 10-Q · filed 2021-05-17 | $421.00K derived: sum of 2 quarters · filed 2021-05-17 | $651.00K derived: sum of 3 quarters · filed 2021-05-17 | $866.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $447.00K derived: sum of 2 quarters · filed 2021-03-31 | $662.00K derived: sum of 3 quarters · filed 2021-03-31 | $893.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $230.00K 10-Q · filed 2020-11-12 | $445.00K derived: sum of 2 quarters · filed 2020-11-12 | $676.00K 10-Q · filed 2020-11-12 | $958.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $215.00K 10-Q · filed 2020-08-14 | $446.00K 10-Q · filed 2020-08-14 | $728.00K derived: sum of 3 quarters · filed 2020-08-14 | $936.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $231.00K 10-Q · filed 2020-05-14 | $513.00K derived: sum of 2 quarters · filed 2020-05-14 | $721.00K derived: sum of 3 quarters · filed 2020-05-14 | $907.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $490.00K derived: sum of 2 quarters · filed 2020-03-30 | $676.00K derived: sum of 3 quarters · filed 2020-03-30 | $884.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $208.00K 10-Q · filed 2019-11-14 | $394.00K derived: sum of 2 quarters · filed 2019-11-14 | $602.00K 10-Q · filed 2019-11-14 | $898.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $186.00K 10-Q · filed 2019-08-14 | $394.00K 10-Q · filed 2019-08-14 | $690.00K derived: sum of 3 quarters · filed 2019-08-14 | $1.09M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $208.00K 10-Q · filed 2019-05-15 | $504.00K derived: sum of 2 quarters · filed 2019-05-15 | $903.00K derived: sum of 3 quarters · filed 2019-05-15 | $1.12M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $695.00K derived: sum of 2 quarters · filed 2019-04-01 | $913.00K derived: sum of 3 quarters · filed 2019-04-01 | $1.18M 10-K · filed 2019-04-01 |
| 2017-09-30 | $399.00K 10-Q · filed 2018-11-14 | $617.00K derived: sum of 2 quarters · filed 2018-11-14 | $887.00K 10-Q · filed 2018-11-14 | $1.17M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $218.00K 10-Q · filed 2018-08-14 | $488.00K 10-Q · filed 2018-08-14 | $766.00K derived: sum of 3 quarters · filed 2018-08-14 | $1.04M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $270.00K 10-Q · filed 2018-05-15 | $548.00K derived: sum of 2 quarters · filed 2018-05-15 | $820.00K derived: sum of 3 quarters · filed 2018-05-15 | $1.11M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $550.00K derived: sum of 2 quarters · filed 2018-03-30 | $840.00K derived: sum of 3 quarters · filed 2018-03-30 | $1.11M 10-K · filed 2018-03-30 |
| 2016-09-30 | $272.00K 10-Q · filed 2017-11-14 | $562.00K derived: sum of 2 quarters · filed 2017-11-14 | $830.00K 10-Q · filed 2017-11-14 | $1.20M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-06-30 | $290.00K 10-Q · filed 2017-08-14 | $558.00K 10-Q · filed 2017-08-14 | $924.00K derived: sum of 3 quarters · filed 2018-03-30 | $1.28M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-03-31 | $268.00K 10-Q · filed 2017-05-15 | $634.00K derived: sum of 2 quarters · filed 2018-03-30 | $987.00K derived: sum of 3 quarters · filed 2018-03-30 | $1.49M derived: sum of 4 quarters · filed 2018-03-30 |
| 2015-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $719.00K derived: sum of 2 quarters · filed 2018-03-30 | $1.23M derived: sum of 3 quarters · filed 2018-03-30 | $1.60M 10-K · filed 2018-03-30 |
| 2015-09-30 | $353.00K 10-Q · filed 2016-11-14 | $860.00K derived: sum of 2 quarters · filed 2016-11-14 | $1.23M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $507.00K 10-Q · filed 2016-08-15 | $879.00K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $372.00K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $1.25M 10-K · filed 2017-03-31 | |||
| 2013-12-31 | $1.23M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |